Process development for “IFN Hybrid

01.08.2025 - 31.05.2026
Research funding project

People

Project leader

Institute

Contract/collaboration

  • pharma& Schweiz GmbH

Research focus

  • Biological and Bioactive Materials: 100%

Publications